HBM Partners

Venture Capital

Swiss healthcare investor with $2.1B AUM, focusing on biopharma, medtech, diagnostics in Europe, North America, and emerging markets.

Zug, Switzerland · 12+ investments · 48 portfolio companies

Seed
Early Stage
Late Stage
Growth
Biotech
Diagnostics
Healthcare
Medtech
Headquarters
Zug, Switzerland
Founded
2001
AUM
$2.8B
Portfolio Companies
48
Total Investments
12
Last Investment
Sep 2025
Geographic Focus
Europe, North America, India, China

Investment Thesis

Source, analyze, and support growth of healthcare companies through venture, growth, and buy-out financings, leveraging global network.

HBM Partners is a Venture Capital firm based in Zug, Switzerland. It has made 12 investments, including Neuron23, Genalyte and Ignis Therapeutics. Focus areas include Biotech and Diagnostics.

Portfolio48

Co-investors24

Sign up to view co-investors

24 co-investors across 99 shared portfolio companies — who they back alongside, and how often they lead.

Venture Capital ×18 · Hedge Fund ×3 · Corporate VC ×3 · 10 shared rounds

Investment History

Sign up to view investment history

Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.

Your firm? Embed this profile

Add the live badge to your site — it stays current as your portfolio data updates.

HBM Partners on Indexed.vc
<a href="https://indexed.vc/investors/hbm-partners"><img src="https://indexed.vc/api/badge/investor/hbm-partners" alt="HBM Partners on Indexed.vc" width="260" height="76" /></a>